{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:16:56Z","timestamp":1789737416481,"version":"4.0.1"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"crossref","award":["HL-068673"],"award-info":[{"award-number":["HL-068673"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"name":"T-32 training","award":["HL-110853"],"award-info":[{"award-number":["HL-110853"]}]},{"name":"American Heart Association Grant-In-Aid","award":["14GRNT20380854"],"award-info":[{"award-number":["14GRNT20380854"]}]},{"name":"State of Wisconsin Partnership Program New Investigator Award","award":["ID2832"],"award-info":[{"award-number":["ID2832"]}]},{"name":"University of Wisconsin ICTR-Clinical and Type 1 Translational Research Pilot Program","award":["UL1TR000427"],"award-info":[{"award-number":["UL1TR000427"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.jconrel.2016.05.002","type":"journal-article","created":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T01:46:15Z","timestamp":1463017575000},"page":"174-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Periadventitial drug delivery for the prevention of intimal hyperplasia following open surgery"],"prefix":"10.1016","volume":"233","author":[{"given":"Mirnal A.","family":"Chaudhary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian-Wang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoqin","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Craig","family":"Kent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2016.05.002_bb0005","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.jvs.2011.11.061","article-title":"Population-based analysis of inpatient vascular procedures and predicting future workload and implications for training","volume":"55","author":"Jim","year":"2012","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0010","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/j.jacc.2004.08.064","article-title":"Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study","volume":"44","author":"Goldman","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0015","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jtcvs.2015.07.027","article-title":"The no-touch saphenous vein for coronary artery bypass grafting maintains a patency, after 16years, comparable to the left internal thoracic artery: a randomized trial","volume":"150","author":"Samano","year":"2015","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0020","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0002-9440(10)63099-4","article-title":"Early adaptive responses of the vascular wall during venous arterialization in mice","volume":"164","author":"Kwei","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0025","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","article-title":"Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial","volume":"131","author":"Tepe","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2016.05.002_bb0030","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/j.jacc.2013.03.034","article-title":"Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies","volume":"61","author":"Dake","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0035","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1161\/CIRCULATIONAHA.106.675934","article-title":"Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications","volume":"115","author":"Luscher","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2016.05.002_bb0040","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1161\/01.ATV.17.3.417","article-title":"Vascular myofibroblasts. Lessons from coronary repair and remodeling","volume":"17","author":"Zalewski","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0045","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.coph.2012.02.012","article-title":"Perivascular administration of drugs and genes as a means of reducing vein graft failure","volume":"12","author":"Wiedemann","year":"2012","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0050","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0039-6060(99)70172-8","article-title":"Optimization of ex vivo inducible nitric oxide synthase gene transfer to vein grafts","volume":"126","author":"Kibbe","year":"1999","journal-title":"Surgery"},{"key":"10.1016\/j.jconrel.2016.05.002_bb0055","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/S0735-1097(97)00123-X","article-title":"Drug clearance and arterial uptake after local perivascular delivery to the rat carotid artery","volume":"29","author":"Lovich","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0060","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S1051-0443(07)61344-X","article-title":"Kinetics of release of heparin from alginate hydrogel","volume":"11","author":"McLennan","year":"2000","journal-title":"J. Vasc. Interv. Radiol."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0065","article-title":"Periadventitial application of rapamycin-loaded nanoparticles produces sustained inhibition of vascular restenosis","volume":"9","author":"Shi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2016.05.002_bb0070","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1016\/j.ijcard.2013.04.153","article-title":"Local inhibition of ornithine decarboxylase reduces vascular stenosis in a murine model of carotid injury","volume":"168","author":"Forte","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0075","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jconrel.2010.05.005","article-title":"Correlation of tissue drug concentrations with in vivo magnetic resonance images of polymer drug depot around arteriovenous graft","volume":"146","author":"Owen","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.05.002_bb0080","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.jvs.2012.12.069","article-title":"Local drug delivery to prevent restenosis","volume":"57","author":"Seedial","year":"2013","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0085","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1161\/01.RES.82.3.295","article-title":"Gene therapy for restenosis: getting nearer the heart of the matter","volume":"82","author":"Baek","year":"1998","journal-title":"Circ. Res."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0090","doi-asserted-by":"crossref","first-page":"H2388","DOI":"10.1152\/ajpheart.00185.2008","article-title":"Heightened efficacy of nitric oxide-based therapies in type II diabetes mellitus and metabolic syndrome","author":"Ahanchi","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jconrel.2016.05.002_bb0095","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.polymer.2008.01.027","article-title":"Hydrogels in drug delivery: progress and challenges","volume":"49","author":"Hoare","year":"2008","journal-title":"Polymer"},{"key":"10.1016\/j.jconrel.2016.05.002_bb0100","first-page":"339","article-title":"Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations","volume":"9","author":"Escobar-Chavez","year":"2006","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0105","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0168-3659(01)00276-0","article-title":"Biodegradable block copolymers for delivery of proteins and water-insoluble drugs","volume":"72","author":"Zentner","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.05.002_bb0110","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jvs.2007.09.005","article-title":"Nitric oxide and nanotechnology: a novel approach to inhibit neointimal hyperplasia","volume":"47","author":"Kapadia","year":"2008","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0115","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0168-3659(01)00248-6","article-title":"On the importance and mechanisms of burst release in matrix-controlled drug delivery systems","volume":"73","author":"Huang","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.05.002_bb0120","first-page":"2391","article-title":"Poloxamer-based binary hydrogels for delivering tramadol hydrochloride: sol-gel transition studies, dissolution-release kinetics, in vitro toxicity, and pharmacological evaluation","author":"dos Santos","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2016.05.002_bb0125","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0168-3659(99)00194-7","article-title":"Drug release from biodegradable injectable thermosensitive hydrogel of PEG-PLGA-PEG triblock copolymers","volume":"63","author":"Jeong","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.05.002_bb0130","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jconrel.2011.06.027","article-title":"Affinity-based growth factor delivery using biodegradable, photocrosslinked heparin-alginate hydrogels","volume":"154","author":"Jeon","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.05.002_bb0135","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/term.1688","article-title":"PEG hydrogel degradation and the role of the surrounding tissue environment","volume":"9","author":"Reid","year":"2015","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0140","doi-asserted-by":"crossref","first-page":"28023","DOI":"10.1039\/C5RA01679G","article-title":"PNIPAM Hydrogel Induces Skeletal Muscle Inflammation Response","volume":"5","author":"Zhu","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0145","first-page":"3","article-title":"In-vitro release of rapamycin from a thermosensitive polymer for the inhibition of vascular smooth muscle cell proliferation","volume":"1","author":"Zhu","year":"2009","journal-title":"J. Bioequiv. Availab."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0150","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jconrel.2012.04.029","article-title":"A biodegradable perivascular wrap for controlled, local and directed drug delivery","volume":"161","author":"Sanders","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.05.002_bb0155","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.biomaterials.2008.12.083","article-title":"Thermosensitive poly(organophosphazene)-paclitaxel conjugate gels for antitumor applications","volume":"30","author":"Chun","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.05.002_bb0160","doi-asserted-by":"crossref","first-page":"40465","DOI":"10.1002\/app.40465","article-title":"Stabilization of pluronic gels in the presence of different polysaccharides","volume":"131","author":"Kj\u00f8niksen","year":"2015","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0165","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1021\/cr000108x","article-title":"Hydrogels for tissue engineering","volume":"101","author":"Lee","year":"2001","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jconrel.2014.05.017","article-title":"A rapamycin-releasing perivascular polymeric sheath produces highly effective inhibition of intimal hyperplasia","volume":"191","author":"Yu","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.05.002_bb0175","doi-asserted-by":"crossref","first-page":"280","DOI":"10.5435\/00124635-200109000-00001","article-title":"Bioabsorbable implants in orthopaedics: new developments and clinical applications","volume":"9","author":"Ciccone","year":"2001","journal-title":"J. Am. Acad. Orthop. Surg."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0180","doi-asserted-by":"crossref","first-page":"5386","DOI":"10.1016\/j.biomaterials.2005.01.063","article-title":"Local perivascular delivery of anti-restenotic agents from a drug-eluting poly(epsilon-caprolactone) stent cuff","volume":"26","author":"Pires","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.05.002_bb0185","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ijpharm.2012.02.023","article-title":"A perivascular system releasing sirolimus prevented intimal hyperplasia in a rabbit model in a medium-term study","volume":"427","author":"Skalsky","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0190","doi-asserted-by":"crossref","first-page":"H1419","DOI":"10.1152\/ajpheart.00914.2013","article-title":"Periadventitial atRA citrate-based polyester membranes reduce neointimal hyperplasia and restenosis after carotid injury in rats","volume":"307","author":"Gregory","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0195","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/mabi.201000509","article-title":"Poly(diol-co-citrate)s as novel elastomeric perivascular wraps for the reduction of neointimal hyperplasia","volume":"11","author":"Serrano","year":"2011","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0200","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/14017430701747108","article-title":"Inhibition of vein graft intimal hyperplasia by periadventitial application of hyaluronic acid-carboxymethyl cellulose: an experimental study","volume":"42","author":"Bahcivan","year":"2008","journal-title":"Scand. Cardiovasc. J."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0205","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/ndt\/gfr667","article-title":"Safety and efficacy of local periadventitial delivery of sirolimus for improving hemodialysis graft patency: first human experience with a sirolimus-eluting collagen membrane (Coll-R)","volume":"27","author":"Paulson","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0210","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.nano.2011.05.016","article-title":"Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging","volume":"8","author":"Parveen","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2016.05.002_bb0215","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/cmdc.200600171","article-title":"Topical delivery of silver nanoparticles promotes wound healing","volume":"2","author":"Tian","year":"2007","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jconrel.2016.05.002_bb0220","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1007\/s10620-006-9738-4","article-title":"Effects of nanocrystalline silver (NPI 32101) in a rat model of ulcerative colitis","volume":"52","author":"Bhol","year":"2007","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0225","doi-asserted-by":"crossref","first-page":"9810","DOI":"10.1016\/j.biomaterials.2011.08.085","article-title":"The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles","volume":"32","author":"Park","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.05.002_bb0230","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.clpt.6100400","article-title":"Nanoparticles in medicine: therapeutic applications and developments","volume":"83","author":"Zhang","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0235","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.biomaterials.2015.01.006","article-title":"Multi-functional self-fluorescent unimolecular micelles for tumor-targeted drug delivery and bioimaging","volume":"47","author":"Chen","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.05.002_bb0240","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/SLA.0000000000001605","article-title":"Targeted Nanotherapies for the treatment of surgical diseases","volume":"263","author":"Morgan","year":"2016","journal-title":"Ann. Surg."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0245","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.phrs.2010.03.005","article-title":"Targeting nanoparticles to cancer","volume":"62","author":"Wang","year":"2010","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0250","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1158\/1535-7163.MCT-07-0615","article-title":"Antitumor activity of an epithelial cell adhesion molecule targeted nanovesicular drug delivery system","volume":"6","author":"Hussain","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0255","doi-asserted-by":"crossref","first-page":"175","DOI":"10.7150\/thno.7210","article-title":"Nanoparticle drug- and gene-eluting stents for the prevention and treatment of coronary restenosis","volume":"4","author":"Yin","year":"2014","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2016.05.002_bb0260","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1161\/CIRCINTERVENTIONS.109.864660","article-title":"Periadventitial rapamycin-eluting microbeads promote vein graft disease in long-term pig vein-into-artery interposition grafts","volume":"3","author":"Rajathurai","year":"2010","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0265","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/gt.2010.69","article-title":"Local arterial nanoparticle delivery of siRNA for NOX2 knockdown to prevent restenosis in an atherosclerotic rat model","volume":"17","author":"Li","year":"2010","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0270","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1161\/CIRCINTERVENTIONS.113.000195","article-title":"Adventitial nab-rapamycin injection reduces porcine femoral artery luminal stenosis induced by balloon angioplasty via inhibition of medial proliferation and adventitial inflammation","volume":"6","author":"Gasper","year":"2013","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0275","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ejps.2012.12.006","article-title":"A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics","volume":"48","author":"Steichen","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0280","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrd2614","article-title":"Nanoparticle therapeutics: an emerging treatment modality for cancer","volume":"7","author":"Davis","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0285","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1016\/j.biomaterials.2009.02.011","article-title":"Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(l-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery","volume":"30","author":"Prabaharan","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.05.002_bb0290","doi-asserted-by":"crossref","first-page":"8323","DOI":"10.1016\/j.biomaterials.2013.07.085","article-title":"Image-guided and tumor-targeted drug delivery with radiolabeled unimolecular micelles","volume":"34","author":"Guo","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.05.002_bb0295","doi-asserted-by":"crossref","first-page":"5244","DOI":"10.1016\/j.biomaterials.2013.03.006","article-title":"Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer","volume":"34","author":"Xu","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.05.002_bb0300","doi-asserted-by":"crossref","first-page":"19347","DOI":"10.1073\/pnas.1115945108","article-title":"In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticles","volume":"108","author":"Chan","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0305","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","article-title":"Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles","volume":"307","author":"Owens","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0310","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0169-409X(95)00026-4","article-title":"The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres","volume":"16","author":"Gref","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0315","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0168-3659(99)00063-2","article-title":"Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting","volume":"60","author":"Peracchia","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.05.002_bb0320","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijpharm.2006.10.020","article-title":"ABA and BAB type triblock copolymers of PEG and PLA: a comparative study of drug release properties and \u201cstealth\u201d particle characteristics","volume":"334","author":"He","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0325","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.jvs.2009.07.108","article-title":"Multicenter phase I\/II trial of the safety of allogeneic endothelial cell implants after the creation of arteriovenous access for hemodialysis use: the V-HEALTH study","volume":"50","author":"Conte","year":"2009","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0330","doi-asserted-by":"crossref","first-page":"376","DOI":"10.5301\/jva.5000235","article-title":"Application of human type I pancreatic elastase (PRT-201) to the venous anastomosis of arteriovenous grafts in patients with chronic kidney disease","volume":"15","author":"Dwivedi","year":"2014","journal-title":"J. Vasc. Access"},{"key":"10.1016\/j.jconrel.2016.05.002_bb0335","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jvs.2014.02.037","article-title":"Human type I pancreatic elastase treatment of arteriovenous fistulas in patients with chronic kidney disease","volume":"60","author":"Hye","year":"2014","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0340","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1001\/jama.294.19.2446","article-title":"Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial","volume":"294","author":"Alexander","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jconrel.2016.05.002_bb0345","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jvs.2005.12.058","article-title":"Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery","volume":"43","author":"Conte","year":"2006","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.jconrel.2016.05.002_bb0350","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S0140-6736(99)09405-2","article-title":"Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial","volume":"354","author":"Mann","year":"1999","journal-title":"Lancet"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916302565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916302565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T09:55:08Z","timestamp":1718531708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365916302565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":70,"alternative-id":["S0168365916302565"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.05.002","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Periadventitial drug delivery for the prevention of intimal hyperplasia following open surgery","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}